Navigation Links
Grassrootshealth Launches D*action Community Project to Solve Vitamin D Deficiency Crisis
Date:11/28/2008

health and disease prevention," said Carole Baggerly, Director of GrassrootsHealth.

"We are very excited to have 18 scientists from the University join together for this major public health action," added Baggerly. "The general public is clamoring for more detailed information on vitamin D and action to be taken. In fact, they are moving faster than the medical community which is why we're moving forward with these seminars. Testing is the key right now. Many people just don't believe there is a problem until they see the test results. Towards that end, we will be announcing a major testing initiative at the conference."

With new vitamin D research appearing daily, questions abound as to how it can be applied to disease prevention or whether its deficiency causes many common diseases such as hypertension, Type 1 diabetes and Multiple Sclerosis, among others.

Major goals of the D*action Community Project include preventing 20-50% of breast cancer, colon cancer, Type 1 diabetes, and cardiovascular diseases in five years by fostering greater awareness for the preventive health benefits of vitamin D.

Membership in the D*action Community Project is open to individuals and groups. Individual membership is a commitment to solving the vitamin D deficiency crisis by taking the following action steps:

Get your serum levels measured; establish your own personal range 40-60 ng/ml recommended

Download the Scientists Call to Action and the Disease Incidence Prevention Chart from www.grassrootshealth.org and send to your friends

Help schedule community seminars about vitamin D and spread the word about upcoming seminars and new information from GrassrootsHealth

Groups and institutions are encouraged to schedule community and/or department seminars in their organizations and spread the
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International Medical Corps Launches Online Catalog Offering Gifts That Save the Lives of Those in Need
2. ClutchWave LLC Launches PricePlow.com: Price Shopping For Supplements and Vitamins
3. ProstateCradle.com Launches the First “External Prostate Massager” by Enviromax, a Sensational Way to Help Millions of Men Have Healthier Prostate Glands
4. Teen Pop Star, Chantel Chani Christie, Launches the Chani Girl Foundation to Bring Education/Awareness on HIV/AIDS
5. MidCap Financial Launches Commercial Finance Company With Over $500 Million of Equity
6. Collexis Launches Innovative Reviewer Finder to Enhance the $30 Billion Health Research Grant Industry
7. DaVita.com Launches Physician Website
8. UT Houston launches geriatric training with $3.25 million in grant, matching funds
9. NursingCenter.com Launches New Features to Improve User Experience
10. Yankee Equity Solution ("YES") Launches $50 Million Fund for Mass.-Based Medtech Companies
11. NTT DATA Launches First Self-Designed DATATRAK eClinical(TM) Project Into Production in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:REES Announces New Baltimore Office 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:NVHR Offers Congressman Hank Johnson Support & Encouragement as He Battles Chronic Hepatitis C Virus 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 2Health News:Washington Regional Partners with U.S. Preventive Medicine to Bring a New Level of Preventive Health Care Services to Northwest Arkansas 3
Other Medicine News:Health News:Avocados may help prevent oral cancer, OSU study shows 2Health News:Ovation further advances development pipeline with new phase III epilepsy study 2Health News:Research Links TV/Video Game Playing With Child Obesity; Health Experts Back a New Approach 2Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 2Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 3Health News:Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows 4Health News:Biotech Finishes on a High in August, Burrill Report Says 2Health News:Biotech Finishes on a High in August, Burrill Report Says 3Health News:Biotech Finishes on a High in August, Burrill Report Says 4Health News:Biotech Finishes on a High in August, Burrill Report Says 5Health News:UPMC Health Plan Launches New Personal Health Record 2Health News:UPMC Health Plan Launches New Personal Health Record 3
Breaking Medicine Technology:For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 1Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 2Prize4Life and the Alzheimer Research Forum Announce Launch of New Web Portal for ALS Research 47980 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 1MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 2MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 3MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 4MassMutual Survey 3A Female Cancer Survivors Better Prepared Financially Than Other Women For Lifes Unexpected Events 47976 5Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 1Association found between Parkinsons disease and pesticide exposure in French farm workers 47972 2
Other Medicine Technology:New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 2New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 3New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 4New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 5New Keppra XR(TM) Data Highlight Its Role for Patients with Partial-Onset Seizures 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 2Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 3Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 4Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 5Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 6Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 7Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 8Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 9Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 10Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 11Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 12Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia 13